GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

pucolentimab   Click here for help

GtoPdb Ligand ID: 13886

Synonyms: HX-008 | HX008 | Puyouheng®
Approved drug
pucolentimab is an approved drug
Compound class: Antibody
Comment: Pucolentimab (formerly HX008) is an anti-PD-1 immune checkpoint inhibitor monoclonal antibody [2]. It blocks interactions between PD-1 and its ligands PD-L1 and PD-L2, and this reactivates a T cell-mediated antitumour response. Pucolentimab has negligible binding to Fc-gamma receptors (FcγRIIIa) or or C1q and therefore exhibits minimal ADCC and CDC activity [2].
Click here for help
References
1. Dhillon S. (2022)
Pucotenlimab: First Approval.
Drugs, 82 (15): 1557-1564. [PMID:36308601]
2. Zhang J, Huang Y, Xi G, Zhang F. (2020)
HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic properties.
MAbs, 12 (1): 1724751. [PMID:32106752]